Looking for factors affecting functioning in euthymic patients with bipolar I disorder: the importance of cognitive complaints and BDNF's Val66Met polymorphism

被引:4
|
作者
Yoldi-Negrete, Maria [1 ]
Palacios-Cruz, Lino [1 ]
Tirado-Duran, Elsa [2 ]
Ivonne Jimenez-Rodriguez, Laura [2 ]
Jimenez-Pavon, Joanna [3 ]
Hernandez, Sandra [4 ]
Aguilar, Alejandro [4 ]
Pamela Morales-Cedillo, Ingrid [4 ]
Jimenez-Tirado, Mariana [5 ]
Fresan-Orellana, Ana [1 ]
Juarez Garcia, Francisco [6 ]
Becerra-Palars, Claudia [7 ]
Camarena-Medellin, Beatriz [4 ]
机构
[1] Inst Nacl Psiquiatria Ramon de la Fuente Muniz, Lab Epidemiol Clin, Subdirecc Invest Clin, Mexico City, DF, Mexico
[2] Inst Nacl Psiquiatria Ramon de la Fuente Muniz, Dept Neuropsicol, Direcc Serv Clin, Mexico City, DF, Mexico
[3] Inst Nacl Psiquiatria Ramon de la Fuente Muniz, Direcc Serv Clin, Clin Trastornos Afectivos, Mexico City, DF, Mexico
[4] Inst Nacl Psiquiatria Ramon de la Fuente Muniz, Dept Farmacogenet, Subdirecc Invest Clin, Mexico City, DF, Mexico
[5] Hosp Med Sur, Dept Ensenanza, Mexico City, DF, Mexico
[6] Inst Nacl Psiquiatria Ramon de la Fuente Muniz, Direcc Invest Epidemiol & Sociales, Mexico City, DF, Mexico
[7] Inst Nacl Psiquiatria Ramon de la Fuente Muniz, Direcc Serv Clin, Mexico City, DF, Mexico
关键词
Bipolar disorder; Functionality; Cognition; Val66Met; BDNF; RATING ASSESSMENT COBRA; QUALITY-OF-LIFE; NEUROTROPHIC FACTOR; PERFORMANCE; SCHIZOPHRENIA; ANXIETY; IMPAIRMENT; RECOVERY; MOOD; ASSOCIATION;
D O I
10.1016/j.jad.2022.01.006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Functioning in Bipolar Disorder (BD) is affected in a substantial proportion of patients. The impact of demographic, clinical, cognitive, and genetic factors on functioning has been shown individually; however, as a complex phenomenon, a global approach to identify the most relevant as well as possible interactions is needed. Methods: 102 patients with type I BD in euthymia were invited for evaluation of demographic, clinical, and cognitive characteristics as well as genotype for Val66Met polymorphism of BDNF gene to determine those associated with poor functioning according to the FAST scale cut-off score. Clinical evaluation included assessment of residual affective symptoms and anxiety. Cognitive evaluation included the COBRA scale, verbal memory, and executive functions testing. Results: Residual depressive symptoms, anxiety, cognitive complaints and being a Met carrier were more frequent in the poor functioning group and were entered in a logistic regression model. Being a Met carrier (OR=4.46, CI=1.19-16.67) and cognitive complaints (OR=1.29, CI= 1.13-1.46) were the most important predictors of poor functioning in type I BD. Limitations: Cross-sectional study, with select population limiting generalizability of findings. Conclusions: A better understanding of underlying factors affecting cognition, including the possible involvement of BDNF Val66Met polymorphism, its systematic evaluation and a continued search for targeted treatment, along with recognition and attention of residual affective and anxious symptoms might improve psychosocial outcomes such as functioning in this population.
引用
收藏
页码:131 / 138
页数:8
相关论文
共 50 条
  • [41] BDNF Val66Met polymorphism and peripheral protein levels in pediatric bipolar disorder and attention-deficit/hyperactivity disorder
    Zeni, C. P.
    Tramontina, S.
    Aguiar, B. W.
    Salatino-Oliveira, A.
    Pheula, G. F.
    Sharma, A.
    Stertz, L.
    Moreira Maia, C. R.
    Hutz, M.
    Kapczinski, F. P.
    Rohde, L. A.
    ACTA PSYCHIATRICA SCANDINAVICA, 2016, 134 (03) : 268 - 274
  • [42] Plasma brain-derived neurotrophic factor (BDNF) concentration and the BDNF Val66Met polymorphism in suicide: a prospective study in patients with depressive disorder
    Ai, Ming
    Wang, Jun
    Chen, Jianmei
    Wang, Wo
    Xu, Xiaoming
    Gan, Yao
    Li, Xuemei
    Gou, Xinyuan
    Cao, Jun
    Lv, Zhen
    Chen, Xiaorong
    Wang, Hengguang
    Ma, Qing
    Kuang, Li
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2019, 12 : 97 - 106
  • [43] An Observational Case-control Study for BDNF Val66Met Polymorphism and Serum BDNF in Patients with Major Depressive Disorder (MDD)
    Ramawat, Raja Babu
    Quraishi, Rizwana
    Deep, Raman
    Kumar, Ram
    Mishra, Ashwani Kumar
    Jain, Raka
    INDIAN JOURNAL OF PSYCHOLOGICAL MEDICINE, 2024,
  • [44] The relationship between the Met allele of the BDNF Val66Met polymorphism and impairments in decision making under ambiguity in patients with obsessive-compulsive disorder
    da Rocha, F. F.
    Malloy-Diniz, L.
    Lage, N. V.
    Correa, H.
    GENES BRAIN AND BEHAVIOR, 2011, 10 (05) : 523 - 529
  • [45] BDNF VAL66MET polymorphism and memory decline across the spectrum of Alzheimer's disease
    Lim, Yen Ying
    Laws, Simon M.
    Perin, Stephanie
    Pietrzak, Robert H.
    Fowler, Christopher
    Masters, Colin L.
    Maruff, Paul
    GENES BRAIN AND BEHAVIOR, 2021, 20 (05)
  • [46] Association Between BDNF Val66Met Polymorphism and Cognitive Performance in Antipsychotic-Naïve Patients with Schizophrenia
    Weihong Lu
    Chen Zhang
    Zhenghui Yi
    Zezhi Li
    Zhiguo Wu
    Yiru Fang
    Journal of Molecular Neuroscience, 2012, 47 : 505 - 510
  • [47] Meta-analysis of BDNF Val66Met polymorphism association with treatment response in patients with major depressive disorder
    Zou, Yan-Feng
    Ye, Dong-Qing
    Feng, Xiao-Liang
    Su, Hong
    Pan, Fa-Ming
    Liao, Fang-Fang
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 (08) : 535 - 544
  • [48] The BDNF Val66Met Polymorphism Modulates Resilience of Neurological Functioning to Brain Ageing and Dementia: A Narrative Review
    Brown, Donnamay T.
    Vickers, James C.
    Stuart, Kimberley E.
    Cechova, Katerina
    Ward, David D.
    BRAIN SCIENCES, 2020, 10 (04)
  • [49] Interaction Between BDNF Val66Met and APOE4 on Biomarkers of Alzheimer's Disease and Cognitive Decline
    Stonnington, Cynthia M.
    Velgos, Stefanie N.
    Chen, Yinghua
    Syed, Sameena
    Huentelman, Matt
    Thiyyagura, Pradeep
    Lee, Wendy
    Richholt, Ryan
    Caselli, Richard J.
    Locke, Dona E. C.
    Lu, Bai
    Reiman, Eric M.
    Su, Yi
    Chen, Kewei
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 78 (02) : 721 - 734
  • [50] Association analysis of brain-derived neurotrophic factor (BDNF) gene Val66Met polymorphism in schizophrenia and bipolar affective disorder
    Skibinska, M
    Hauser, J
    Czerski, PM
    Leszczynska-Rodziewicz, A
    Losmowska, M
    Kapelski, P
    Slopien, A
    Zakrzewska, M
    Rybakowski, JK
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2004, 5 (04) : 215 - 220